Anti-IFNAR or anti-NKG2D treatment of B6.MRL/lpr mice remarkably restored Treg cell numbers and ameliorated the lupus disease, confirming the substantial contribution of NKG2D+CD4+ T cells to the decrease in Treg cells observed in SLE patients. The gene discussed is KLRK1; the disease is systemic lupus erythematosus.